Use of anastrozole for the treatment of post-menopausal...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4196 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2468965

The invention provides the use of anastrozole, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for the reduction of the rate of recurrence of cancer in a woman having early breast cancer. The invention further provides the use of anastrozole, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for the reduction of the rate of a new contralateral primary tumour in a post-menopausal woman having early breast cancer.

L'invention a trait à l'utilisation de l'anastrozole, ou d'un sel pharmaceutiquement acceptable de ce dernier, pour la préparation d'un médicament destiné à réduire le taux de récidive du cancer chez les femmes souffrant d'un cancer du sein à un stade précoce. L'invention se rapporte également à l'utilisation de l'anastrozole, ou d'un sel pharmaceutiquement acceptable de ce dernier, pour la préparation d'un médicament destiné à réduire le risque d'apparition d'une nouvelle tumeur primaire controlatérale chez les femmes ménopausées souffrant d'un cancer du sein à un stade précoce.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of anastrozole for the treatment of post-menopausal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of anastrozole for the treatment of post-menopausal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anastrozole for the treatment of post-menopausal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1886759

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.